We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+8.12%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.82B
AUM Growth
+$110M
Cap. Flow
-$28.2M
Cap. Flow %
-1%
Top 10 Hldgs %
24.59%
Holding
328
New
19
Increased
84
Reduced
138
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 29.95%
2 Healthcare 22.66%
3 Industrials 15.17%
4 Consumer Discretionary 14.57%
5 Communication Services 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THS
226
DELISTED
Treehouse Foods
THS
$1.53M 0.05%
37,726
-3,614
-9% -$140K
AXGN icon
227
Axogen
AXGN
$2.57B
$1.5M 0.05%
160,255
-4,827
-3% -$57.9K
PBYI icon
228
Puma Biotechnology
PBYI
$450M
$1.49M 0.05%
491,282
-55,026
-10% -$239K
SSTI icon
229
SoundThinking
SSTI
$104M
$1.47M 0.05%
49,665
-6,694
-12% -$235K
OPTN
230
DELISTED
OptiNose
OPTN
$1.37M 0.05%
56,411
-5,729
-9% -$192K
YMAB
231
DELISTED
Y-mAbs Therapeutics
YMAB
$1.37M 0.05%
84,395
-14,896
-15% -$318K
CDNA icon
232
CareDx
CDNA
$2.47B
$1.36M 0.05%
29,923
-1,000
-3% -$52.2K
AAPL icon
233
Apple
AAPL
$4.48T
$1.34M 0.05%
7,568
BRK.B icon
234
Berkshire Hathaway Class B
BRK.B
$1.14T
$1.34M 0.05%
4,484
RYTM icon
235
Rhythm Pharmaceuticals
RYTM
$7.91B
$1.27M 0.05%
127,546
-22,174
-15% -$249K
COLM icon
236
Columbia Sportswear
COLM
$2.91B
$1.26M 0.04%
12,964
DENN
237
DELISTED
Denny's
DENN
$1.19M 0.04%
74,427
-10,091
-12% -$155K
PRVB
238
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1.16M 0.04%
206,215
-35,196
-15% -$223K
TDY icon
239
Teledyne Technologies
TDY
$32.3B
$1.14M 0.04%
2,604
NATI
240
DELISTED
National Instruments Corp
NATI
$1.14M 0.04%
26,024
SRRK icon
241
Scholar Rock
SRRK
$6.21B
$1.12M 0.04%
45,071
-6,147
-12% -$170K
AKBA icon
242
Akebia Therapeutics
AKBA
$234M
$1.1M 0.04%
486,220
-79,806
-14% -$218K
CSTL icon
243
Castle Biosciences
CSTL
$1.01B
$1.08M 0.04%
25,213
-3,531
-12% -$185K
ABT icon
244
Abbott
ABT
$188B
$1.07M 0.04%
7,616
-100
-1% -$12.8K
MIXT
245
DELISTED
MIX TELEMATICS LIMITED
MIXT
$986K 0.04%
78,224
-10,622
-12% -$129K
URGN icon
246
UroGen Pharma
URGN
$2.24B
$964K 0.03%
101,359
-47,901
-32% -$675K
ABBV icon
247
AbbVie
ABBV
$433B
$945K 0.03%
6,977
MCO icon
248
Moody's
MCO
$83.2B
$897K 0.03%
2,296
-70
-3% -$27K
HAS icon
249
Hasbro
HAS
$13.3B
$863K 0.03%
8,481
LLY icon
250
Eli Lilly
LLY
$1.09T
$660K 0.02%
2,390

Similar funds

Rice Hall James & Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Rice Hall James & Associates held 328 positions worth $2.82B, up 4.1% from $2.71B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates's Q4 2021 filing shows 19 new, 84 increased, 138 reduced and 16 closed positions. Its largest new stake was Consensus Cloud Solutions: 170,468 shares worth $9.87M. The largest sale was Echo Global Logistics, Inc., an estimated $31.9M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Rice Hall James & Associates's largest Q4 2021 buy was Consensus Cloud Solutions: 170,468 shares worth $9.87M.
  • Rice Hall James & Associates added most to Euronet Worldwide in Q4 2021, an estimated $20.2M increase.
  • Rice Hall James & Associates's biggest Q4 2021 reduction was Ziff Davis, cutting an estimated $15.2M.
  • Rice Hall James & Associates fully exited Echo Global Logistics, Inc. in Q4 2021, selling an estimated $31.9M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $2.82B portfolio in Q4 2021.
  • Rice Hall James & Associates opened 19 new positions and closed 16 in Q4 2021.
  • Rice Hall James & Associates's portfolio value rose 4.1% quarter-over-quarter to $2.82B.

Based on Rice Hall James & Associates's 13F filing for Q4 2021, filed 14 Feb 2022.